NLVP

New Leaf Venture Partners Portfolio holdings

AUM $52.9M
This Quarter Return
+135.1%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$433M
AUM Growth
+$433M
Cap. Flow
-$16.1M
Cap. Flow %
-3.72%
Top 10 Hldgs %
96.06%
Holding
18
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

1
COGT icon
Cogent Biosciences
COGT
$14.7M
2
NERV icon
Minerva Neurosciences
NERV
$1.43M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARVN icon
1
Arvinas
ARVN
$568M
$194M 44.8%
2,283,048
– –
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$69M 15.95%
1,209,571
– –
PASG icon
3
Passage Bio
PASG
$22.7M
$63.9M 14.76%
2,497,922
– –
HARP
4
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$48.5M 11.21%
2,921,405
– –
APTX
5
DELISTED
Aptinyx Inc. Common Stock
APTX
$11.4M 2.63%
3,290,079
– –
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$6.57M 1.52%
409,611
– –
CMRX
7
DELISTED
Chimerix, Inc.
CMRX
$6.52M 1.51%
1,350,000
– –
COGT icon
8
Cogent Biosciences
COGT
$1.69B
$5.5M 1.27%
489,380
-1,306,165
-73% -$14.7M
ARAV
9
DELISTED
Aravive, Inc. Common Stock
ARAV
$5.34M 1.23%
946,423
– –
ALEC icon
10
Alector
ALEC
$238M
$5.14M 1.19%
339,569
– –
CHMA
11
DELISTED
Chiasma, Inc. Common Stock
CHMA
$4.94M 1.14%
1,135,700
– –
TECX
12
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$4.4M 1.02%
315,550
– –
XFOR icon
13
X4 Pharmaceuticals
XFOR
$84.2M
$2.15M 0.5%
335,000
– –
CRNX icon
14
Crinetics Pharmaceuticals
CRNX
$2.92B
$1.99M 0.46%
141,000
– –
OBSV
15
DELISTED
ObsEva SA Ordinary Shares
OBSV
$1.87M 0.43%
900,501
– –
ITRM icon
16
Iterum Therapeutics
ITRM
$30.2M
$1.44M 0.33%
1,456,303
– –
PDSB icon
17
PDS Biotechnology
PDSB
$57.8M
$251K 0.06%
117,242
– –
NERV icon
18
Minerva Neurosciences
NERV
$16.5M
– –
-449,500
Closed -$1.43M